about
Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study.Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.Mitochondrial DNA content and mass increase in progression from normal to hyperplastic to cancer endometrium.Borderline epithelial tumors of the ovary: Experience of 55 patients.Distant metastases in ovarian carcinoma.Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort.Chemoradiation: A new approach for the treatment of cervical cancer.Rapid growth of myxoid leiomyosarcoma of the vulva during pregnancy: a case report.Two cases of endometrial cancer diagnosis associated with bone metastasis.Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studiesNeoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer.Groin recurrence in carcinoma of the vulva: management and outcome.Carcinosarcoma of the ovary: analysis of 13 cases and review of the literature.Mitochondrial changes in endometrial carcinoma: possible role in tumor diagnosis and prognosis (review).Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A Single-Institution Experience and a Review of the Literature.Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study.The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.Primary surgical cytoreduction in advanced ovarian cancer: An outcome analysis within the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group.Robotic approach using simple and radical hysterectomy for endometrial cancer with long-term follow-up evaluation.Serous papillary cystadenoma of borderline malignancy of the broad ligament.Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma.The PGC-1alpha-dependent pathway of mitochondrial biogenesis is upregulated in type I endometrial cancer.The plasma homocysteine levels are increased in polycystic ovary syndrome.Second-line chemotherapy in recurrent clear cell ovarian cancer: results from the multicenter italian trials in ovarian cancer (MITO-9).Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma.Changes in the management and outcome of central nervous system involvement from ovarian cancer since 1994.Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase II study.Prospective randomized study comparing amoxicillin-clavulanic acid with cefazolin as antimicrobial prophylaxis in laparotomic gynecologic surgery.Regulation of the expression of CLU isoforms in endometrial proliferative diseases.Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study.Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience.Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma.Leptomeningeal involvement after remission of brain metastases from ovarian cancer.Locally advanced cervical cancer associated with complete uterine prolapse.Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: Retrospective Analysis From the MITO-9 Group.Non-puerperal uterine inversion due to uterine sarcoma.The role of office hysteroscopy in menopause.Operative office hysteroscopy without anesthesia: analysis of 4863 cases performed with mechanical instruments.The impact of lymph vascular space invasion on recurrence and survival in patients with early stage endometrial cancer.
P50
Q33365433-A6B465B3-99BF-41B0-8BB8-DA213D7D92E6Q33413609-D3836814-BBFC-4DD9-B1F4-0E926AE7BA13Q34296416-6C642C1B-433D-422F-82E0-0A7C51104069Q34993739-B00DF9C0-2785-4AD6-A81B-9F55E39D7AB0Q35092160-1318F035-4EBB-4751-B8F2-5DB9D7A007E9Q35262997-B7AE135E-410F-4107-B673-DB81CEFA0BE2Q35607682-837D566A-95B2-424F-A0C9-258312143279Q35649298-5237056A-E4FD-4EE2-9885-EE80D29369BEQ36271638-F30EAF20-BBD0-4D6E-88DE-63E4423D4CA1Q36554430-C2AF03B2-8D85-4092-A439-28E01BED79BAQ36945491-8AA6C6B1-3F83-4DB8-831B-1F8E6E93DAFBQ37615521-FDD1E52C-49D9-41D8-AB41-EA24A45ECEA6Q37890205-29692C2D-3757-4F85-ABB4-160AB32FBB4EQ38296478-6E868918-6368-48B8-9B2D-799DD8A3D390Q38917140-0A08E082-295E-4F92-B64C-137EDFF854E0Q39211467-CBBA5632-E60D-408F-B411-CF91FA143C06Q39226352-4C772479-2AFD-415C-8BD0-E8B52F3EEA7FQ40042569-90F4D189-7B6F-4B92-8F82-EA38ABE39D58Q41442156-7B22D81B-517A-466A-B782-05FF3DC2783AQ41599053-E785999C-D552-4E41-8F1C-AA5573D827CFQ43239156-65548B67-0CFD-46BE-ADF1-3313EEDF9144Q43253919-498C153B-4010-4E84-8C81-200187BB7C73Q44020064-1AF089E7-D28C-488E-9EFD-4D3B2A6E8D5AQ44056096-08247489-6847-4C87-9F52-370A41058527Q44247526-97CF7B7C-063A-4B12-BB71-BEE58E4D9563Q44312652-5AEABD82-5F38-4141-8C17-ADF50995BBCEQ44389865-F619CA8F-CA73-43CC-8546-DFF5BDEA0585Q44474572-364AD971-B364-4121-8571-85ABE91DB0E5Q44654917-9B673BEF-8495-4B18-9881-99FB20C92AFAQ44806130-7E45E6D0-6B15-46B9-BC77-E22C87686F65Q45730390-97BBDD41-CB5D-45D5-9B30-3EDAE44A5E5FQ45751183-F00E2738-22A7-4D2F-89CA-3C759028828EQ46098313-C295EA6A-E570-48E0-B099-E4560A07F45BQ48106298-AE408F63-991F-4A2A-B0F2-61D5501A9913Q48412199-F3CFD78B-0B48-41D4-ADA3-489AFCF177C7Q48519655-CC7A6CD3-A2FD-47D9-A9E8-816B30255D35Q48726202-E7FD71BC-9906-48E8-A980-E9E615EB9489Q48891991-E7B39EE3-914D-4E00-9516-5D9A6C55D5E0Q48892002-DC00E4AD-2C6E-4274-8E97-082DC092F8EDQ50765383-18A05009-EE2D-4BD8-8C96-177E3EBC062C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gennaro Cormio
@ast
Gennaro Cormio
@en
Gennaro Cormio
@es
Gennaro Cormio
@nl
Gennaro Cormio
@sl
type
label
Gennaro Cormio
@ast
Gennaro Cormio
@en
Gennaro Cormio
@es
Gennaro Cormio
@nl
Gennaro Cormio
@sl
altLabel
gennaro cormio
@en
prefLabel
Gennaro Cormio
@ast
Gennaro Cormio
@en
Gennaro Cormio
@es
Gennaro Cormio
@nl
Gennaro Cormio
@sl
P106
P1153
7005847975
P21
P31
P496
0000-0001-5745-372X